Keisuke Imamura

This inventor holds 19 USPTO granted patents and 6 published patent applications, plus 2 CIPO patents and 8 EPO patents, primarily in Heterocyclic Compounds. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2013-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Keisuke Imamura. Retrieved from https://idiyas.com/inventor/keisuke-imamura

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 19 (Patent Applications = 6)

% Patents Active = 78.9

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 8 (Patent Applications = 7)

Average Co-Inventor Count = 11.2

ph-index = 3

Forward Citations = 52(Granted Patents)

Location History:

Fujisawa, JP (2020 - 2022)
Kanagawa, JP (2013 - 2024)

Company Filing History:

19 out of 1,229

Takeda Pharmaceutical Company Limited

patents

Years Active: 2013-2026

Loading Chart...

Areas of Expertise:

Heterocyclic Compounds

Phosphodiesterase Inhibitors

Condensed Compounds

Fused Compounds

Sleep Disorders

Sulfonamide Derivatives

Cataplexy Treatment

Excessive Sleepiness

Chemical Applications

Medicinal Chemistry

Pharmaceuticals

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12662453 - Heterocyclic compound and use thereof (2026-06-23),

2. 12421188 - Heterocyclic compound and use thereof (2025-09-23),

3. 12415782 - Heterocyclic compound and use thereof (2025-09-16),

4. 12404237 - Method of treating excessive sleepiness and/or cataplexy using n-{2-(([1,1'-biphenyl]-3-yl)methyl)pyrrolidin-3-yl}sulfonamide derivatives (2025-09-02),

5. 12091410 - Heterocyclic compound (2024-09-17),

6. 12071434 - Heterocyclic compound (2024-08-27),

7. 11655241 - Heterocyclic compound and use thereof (2023-05-23),

8. 11440883 - Heterocyclic compound and use thereof (2022-09-13),

9. 11390634 - Fused heterocyclic compound (2022-07-19),

10. 11319286 - Heterocyclic compound and application thereof (2022-05-03),

11. 10981934 - Fused heterocyclic compound (2021-04-20),

12. 10584097 - Heterocyclic compound and use thereof (2020-03-10),

13. 10577382 - Fused heterocyclic compound (2020-03-03),

14. 10428023 - Heterocyclic compound and use thereof (2019-10-01),

15. 9226921 - Fused heterocyclic compounds as phosphodiesterases (PDES) inhibitors (2016-01-05),

Title: The Innovative Journey of Keisuke Imamura

Introduction: Keisuke Imamura is a pioneering inventor hailing from Kanagawa, Japan, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Keisuke Imamura holds several patents in the realm of robotics and artificial intelligence, showcasing his dedication to pushing the boundaries of technological advancement.

Career Highlights: Throughout his illustrious career, Keisuke Imamura has been instrumental in developing cutting-edge solutions that have revolutionized industries. His work has not only garnered recognition but has also significantly impacted the way we interact with technology on a daily basis.

Collaborations: Keisuke Imamura has collaborated with leading tech companies and research institutions, pooling together expertise to create innovative products that have set new standards in the industry. His collaborative efforts have led to the development of futuristic technologies that continue to shape the future.

Conclusion: Keisuke Imamura's relentless pursuit of innovation and his passion for creating transformative technologies have solidified his position as a visionary inventor in the world of technology. His contributions have left an indelible mark on the industry, inspiring future generations to push the boundaries of what is possible.

Profile summary based on public USPTO records.